2024 annual financial data
Zentalis Pharmaceuticals 2024 Operating cash flow margin
Direct answer
Operating cash flow margin was -253.41%.
Operating income was -191,194,000 USD and net income was -165,839,000 USD.
Operating cash flow was -170,860,000 USD.
Get free Zentalis Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 67,425,000 USD
- Operating income
- -191,194,000 USD
- Net income
- -165,839,000 USD
- Operating cash flow
- -170,860,000 USD